I'm a passionate investor with a strong foundation in fundamental analysis and a keen eye for identifying undervalued companies with long-term growth potential. My investment approach is a blend of value investing principles and a focus on long-term growth. I believe in buying quality companies at a discount to their intrinsic value and holding them for the long haul, allowing them to compound their earnings and shareholder returns.Analyst’s Disclosure: I/we have no stock, option or similar derivative posit ...

Wall Street's "fear gauge†was rising on Tuesday as the S&P 500 and other major U.S. equity indexes touched their lowest levels of the year, before an afternoon rebound caused them to recoup much of their earlier losses. ...

Only four move-in ready homes remain available in this sought-after community in Bay Park Clairemont neighborhoodSAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the final opportunity to purchase a luxury new townhome at Mira Vista, an intimate enclave of just 40 home sites in San Diego, California. Only four move-in ready homes remain available in this exceptional community located in the Bay Park Clairemont neighbor ...

Turning our attention over to crypto, which can't break back above 70,000. It's given it multiple tries recently. Mike Willis, co-founder and CEO of Cyber Hornet ETFs, is with me.You may remember Bitcoin was at 127,000 not that long ago. And there are folks who still love it, still believe in it, but they're also looking to Ethereum and XRP and other ways to look at crypto. So, let's talk about what's going on with crypto.um particularly as we have a war in the Middle East. Your thoughts, Mike. >> Yeah, tha ...

Legendary investor Warren Buffett is no longer the CEO of Berkshire Hathaway (NYSE:BRK)(NYSE:BRK) , but he likely had input or was behind the investments the conglomerate made in 2025. That includes a stake in Magnificent Seven stock Alphabet (NASDAQ:GOOGL) , a position that was unveiled after the third quarter.Berkshire Hathaway Sitting on Alphabet Stock GainsBuffett and Berkshire Hathaway unveiled a 17,846,142 share stake in Alphabet in a 13F for the third quarter, making the stock one of the top 10 holdi ...

At a divided Fed, doves likely to rule the roost and push for more rate cuts this year - MarketWatch## Economic Outlook# At a divided Fed, doves likely to rule the roost and push for more rate cuts this year## The inflationary effects of President Trump's tariffs are seen as fadingPublished: March 3, 2026 at 3:53 p.m. ETShareResize---Listen(5 min)Are the doves at the Federal Reserve flying high again? Photo: Agence France- Presse/Getty ImagesThe Federal Reserve has separated into two distinct wings on wheth ...

PresentationJudith ElliottRaymond James Ltd., Research Division Good morning. My name is Judith Elliott, and I'm the analyst covering mining at Raymond James. It's my pleasure today to introduce Chris Vollmershausen, Executive VP, Legal, General Counsel and Corporate Strategy at Agnico Eagle. Agnico is Canada's largest mining company and the second largest gold producer in the world with operating mines in Canada, Australia, Finland and Mexico. The company is advancing a pipeline of high-quality development ...

PresentationI guess we'll get started. Hi, I'm Shane Brett, U.S. semiconductor equipment analyst. I'm honored to host Doug Bettinger, CFO of Lam Research. Before we kick it off with questions, I'd like to pass it to Doug for a safe harbor.Douglas BettingerExecutive VP & CFO Yes, I need to keep my attorneys happy. So let me read the safe harbor real quick and then we can get into the meat and potatoes here. Today's discussion may include forward-looking statements subject to risks and uncertainties, and actu ...

PresentationJoseph ThomeTD Cowen, Research Division Alrighty. Hello, everyone. I think we'll go ahead and get started. Thank you for joining us on day 2 of TD Cowen's 46th Annual Health Care Conference. I'm Joe Thome, one of the senior biotech analysts here on the team at TD Cowen. And it is my pleasure to have with me today several members of the Jazz Pharmaceuticals management team. We have CFO, Phil Johnson. We have the Head of Oncology Clinical Development, Amal Melhem-Bertrandt; and we have Head of Inv ...

Company Overview - The company is excited about its current trajectory of bringing intelligent systems to the edge, indicating a strong conviction in its strategic direction [2]. Industry Environment - The company reported a strong Q4 performance and a positive outlook for Q1, noting that the results are better than expected compared to 90 days prior [3]. - The improvement in Q1 performance is attributed to a robust backlog in both direct and channel sales, with broad-based recovery across all segments year-on-year [3].